342 related articles for article (PubMed ID: 14533729)
1. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.
Amundsen EJ; Eskild A; Stigum H; Smith E; Aalen OO
Eur J Public Health; 2003 Sep; 13(3):252-8. PubMed ID: 14533729
[TBL] [Abstract][Full Text] [Related]
2. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?
Remis RS; Bruneau J; Hankins CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S57-9. PubMed ID: 9663625
[TBL] [Abstract][Full Text] [Related]
3. Study finds legalizing needles reduces HIV risk.
AIDS Policy Law; 1995 Sep; 10(17):1, 11. PubMed ID: 11362806
[TBL] [Abstract][Full Text] [Related]
4. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous drug use and the spread of HIV; an international perspective].
Meijerink H; van Crevel R; van der Ven AJ
Ned Tijdschr Geneeskd; 2013; 157(21):A5690. PubMed ID: 23693006
[TBL] [Abstract][Full Text] [Related]
6. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
7. Syringe access for injection drug users in Rhode Island.
Boutwell A; Rich JD
Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
[No Abstract] [Full Text] [Related]
8. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA; Weinstein B; Burris S; Jones TS
AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Ganju D; Ramesh S; Saggurti N
Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
11. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
14. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.
Gostin LO; Lazzarini Z; Jones TS; Flaherty K
JAMA; 1997 Jan; 277(1):53-62. PubMed ID: 8980211
[No Abstract] [Full Text] [Related]
15. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
[TBL] [Abstract][Full Text] [Related]
16. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.
Jones L; Pickering L; Sumnall H; McVeigh J; Bellis MA
Int J Drug Policy; 2010 Sep; 21(5):335-42. PubMed ID: 20189375
[TBL] [Abstract][Full Text] [Related]
17. Operating needle exchange programmes in the hills of Thailand.
Gray J
AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
[TBL] [Abstract][Full Text] [Related]
18. Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis.
Shrestha S; Smith MW; Broman KW; Farzadegan H; Vlahov D; Strathdee SA
J Acquir Immune Defic Syndr; 2006 Nov; 43(3):335-43. PubMed ID: 16980914
[TBL] [Abstract][Full Text] [Related]
19. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
20. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
Watters JK; Estilo MJ; Clark GL; Lorvick J
JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
